Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 ,inter alia, to consider and approve Board Meeting intimation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Terce Laboratories has informed BSE that its Board of Directors will meet on Monday, 11 August 2025, to consider and approve the Unaudited Financial Results for the quarter ended 30 June 2025 (Q1 FY26). This is a routine filing under SEBI's Listing Regulations (Regulation 29(1)(a)). The company also notes that the trading window for its equity shares was closed from 1 July 2025 and will reopen 48 hours after the results are publicly declared, which is expected on 13 August 2025. No financial figures, revenue numbers, or profit data are disclosed in this intimation.
This is a procedural announcement with no immediate impact on shareholders. Investors should watch for the actual Q1 FY26 results on 13 August 2025 for any meaningful signals on the company's revenue, profitability, or margins.